Search the Newsreel

Enterprise value to revenue forward of Sprott Physical Uranium Trust – NEO:U.UN

Fresenius Medical Care stock holds near $23 as investors weigh latest earnings

NATIONALUM Share Price Today - National Aluminium Company Stock Analysis

Do Manaksia Aluminium's (NSE:MANAKALUCO) Earnings Warrant Your Attention?

Needham & Company LLC Raises Definium Therapeutics (NASDAQ:DFTX) Price Target to $66.00

Needham & Company LLC has increased its price target for Definium Therapeutics (NASDAQ:DFTX) to $66.00 from $50.00, reiterating a "buy" rating after the company's positive Phase 3 results for its DT120 ODT anxiety treatment. Despite reporting a quarterly loss of $1.44 per share, significantly …

Ternium S.A. Stock 12‑Month Price Target Raised to $56.69, Implies 4% Upside

Analysts have raised Ternium S.A.'s average 12-month price target from $56.23 to $56.69, with a range of $40 to $78 per share, suggesting a 4% potential upside from its Aug. 11 closing price. The consensus rating for the stock remains "Buy" among 14 analysts, …

Definium Therapeutics Says Unprecedented Efficacy From Anxiety Study 'Raises the Bar'

Definium Therapeutics announced highly positive Phase 3 results for its drug DT120 ODT (lysergide) in treating generalized anxiety disorder (GAD), demonstrating statistically significant improvement over placebo. The drug also showed rapid and sustained symptom reduction, a favorable safety profile, and is the second successful …

Genius Sports Stock (GENI) Opinions on Q2 Earnings Beat and Outlook Raise

Definium Therapeutics posts positive Phase 3 Voyage topline: DT120 ODT cuts HAM-A by 5.4 pts vs placebo

Definium Therapeutics announced positive topline data from its Phase 3 Voyage study, demonstrating that DT120 ODT significantly reduced HAM-A scores by 5.4 points compared to placebo at Week 12. The study met its primary and all key secondary endpoints, showing rapid onset of effect …

Definium Therapeutics shares surge after positive Phase 3 anxiety trial results

Definium Therapeutics (NASDAQ: DFTX) shares jumped 20% in premarket trading after announcing positive topline results from its Phase 3 Voyage study for DT120 ODT in generalized anxiety disorder. The trial met its primary and secondary endpoints, showing a statistically significant improvement in anxiety scores …

Definium Therapeutics (Nasdaq: DFTX) reports positive DT120 GAD Phase 3 data

Definium Therapeutics (Nasdaq: DFTX) announced positive topline results from its Phase 3 Voyage study of DT120 ODT for generalized anxiety disorder (GAD), meeting its primary and all key secondary endpoints with high statistical significance. The study demonstrated rapid, robust, and durable efficacy, with DT120 …

Definium says LSD-based pill reduces anxiety in late-stage study

Definium Therapeutics' experimental LSD-based pill, DT120, significantly reduced anxiety symptoms in a late-stage study, exceeding investor expectations. The single-dose treatment for generalized anxiety disorder (GAD) showed a statistically and clinically meaningful reduction in symptoms, with benefits appearing early and lasting throughout the 12-week study. …

Genius Sports (NYSE:GENI) Downgraded by Zacks Research to "Strong Sell"

Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder

Definium Therapeutics announced positive topline results from its Phase 3 Voyage study of DT120 ODT for generalized anxiety disorder (GAD), meeting its primary and key secondary efficacy endpoints with statistically significant reductions in HAM-A scores. The study demonstrated rapid, sustained efficacy and a favorable …

Millennium & Copthorne Hotels New Zealand (NZSE:MCK) Stock Faces Sharp Valuation Disconnect

Genius Sports Limited (NYSE:GENI) Receives Average Recommendation of "Moderate Buy" from Analysts

Genius Sports Limited (NYSE:GENI) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $11.44, significantly above its current opening price of $7.74. The company reported strong year-over-year revenue growth of 64.7% to $195.5 million, surpassing estimates, although …

National Aluminium Company Shares Rise 2.85% on NIFTY MIDCAP 150

Raised Guidance and Prediction-Market Deals Could Be A Game Changer For Genius Sports (GENI)

Genius Sports (GENI) reported second-quarter 2026 results with sales of US$195.5 million and a wider net loss of US$76.73 million, but raised its full-year 2026 revenue outlook to over US$1 billion. The company also announced strategic partnerships with Kalshi and Polymarket to integrate its …

Ternium (TX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8 a.m. ET CALL PARTICIPANTS Global IR and Compliance Senior Director - Sebastián MartíChief Executive Officer - Maximo VedoyaChief Financial Officer - Pablo Brizzio TAKEAWAYS Adjusted EBITDA -- $1.2 billion for the first …

Tuniu to Report Second Quarter 2026 Financial Results on August 25, 2026

Tuniu Corporation announced it will release its unaudited financial results for the second quarter ended June 30, 2026, before the market opens on August 25, 2026. The company will host an earnings conference call on the same day at 8:00 AM U.S. Eastern Time, …

Niu Technologies (NIU) Stock Revenue Growth Clashes With Deepening Losses

Niu Technologies (NIU) reported a revenue increase to RMB 1.44 billion in Q2 2026, driven by strong unit growth, particularly in lower-priced electric motorcycles. Despite this revenue growth, the company's profits turned into a net loss of RMB 102.2 million, largely due to a …

Bullish on Ternium SA

Ternium (TX-N) has recently broken out of a four-year horizontal trading pattern, signaling a new uptrend. The stock, which had previously surged from a low of US$9.59 in March 2020 to US$56.86 in August 2021, has now surpassed its multi-year trading range, indicating potential …

Niu Technologies (NIU) stock price, news, quote and history

This article provides a comprehensive overview of Niu Technologies (NIU) stock, including its current price, historical data, financial performance, and analyst insights. It details the company's products, which range from electric scooters and bicycles to accessories and lifestyle items, and outlines its sales and …

Definium Therapeutics (NASDAQ:DFTX) Trading Down 6.2% - Time to Sell?

Definium Therapeutics (NASDAQ:DFTX) saw its shares drop by 6.2% to $42.34 on Tuesday, with trading volume significantly lower than average. Despite this decline and a quarterly loss exceeding analyst estimates, analysts maintain a "Buy" rating with a $55 price target. Insider selling activity has …

DFTX Stock On Track For Worst Day In 9 Months As Investors Brace For Anxiety Trial Data

Shares of Definium Therapeutics (DFTX) dropped 9% as investors await crucial clinical trial data for the company's psychedelic drug, DT120, a one-time therapy for generalized anxiety disorder. This decline marks its worst day in nine months. The company, which has $1.1 billion in cash, …

Manaksia Aluminium Q1 Results: Net profit rises 83% YoY to ₹2.85 crore

H.C. Wainwright Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $70

H.C. Wainwright has reiterated its Buy rating for Definium Therapeutics (DFTX.US) and maintained its target price at $70. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Ternium Announces Second Quarter and First Half of 2026 Results

Ternium S.A. (NYSE:TX) announced strong results for the second quarter and first half of 2026, with Adjusted EBITDA increasing by 50% sequentially to $717 million, driven by higher sales volumes and improved margins in Mexico and Brazil. The company recorded a net income of …

Manaksia Aluminium Board Clears Q1 FY27 Results, Sets AGM and Dividend Record Date

Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026, at 9:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Chair of the Management Board - Helen Giza Chief Financial Officer - Martin Fischer Investor Relations - Dominik Heger Full Conference Call Transcript Operator: …

Insider Sheds Over 55,000 Shares of North American Uranium Stock

Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong …

Q3 EPS Estimates for Genius Sports Cut by Analyst

Northland Securities has cut its Q3 2026 EPS estimate for Genius Sports (NYSE: GENI) to a loss of $0.04 per share, down from a previous estimate of a $0.03 profit. This adjustment comes after Genius Sports reported a Q2 EPS of negative $0.28, missing …

China Mengniu Dairy Stock Slides 1.5% in Hong Kong

NIU Technologies Q2 2026 revenue rises 14.7% but posts RMB 102.2M net loss amid margin pressures

NIU Technologies reported a 14.7% year-over-year revenue increase in Q2 2026, reaching RMB 1,440.4 million, primarily driven by a 24.2% rise in e-scooter sales. However, the company recorded a net loss of RMB 102.2 million, a significant drop from the previous year's net income, …

Genius Sports (NYSE:GENI) Rating Lowered to Strong Sell at Wall Street Zen

Wall Street Zen has downgraded Genius Sports (NYSE:GENI) from "sell" to "strong sell," despite MarketBeat's consensus "Moderate Buy" rating and $11.44 price target. Genius Sports reported higher-than-expected quarterly revenue of $195.5 million, a 64.7% year-over-year increase, but its adjusted loss of $0.28 per share …